Philip Toltzis

2.5k total citations
86 papers, 1.6k citations indexed

About

Philip Toltzis is a scholar working on Epidemiology, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Philip Toltzis has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 28 papers in Infectious Diseases and 18 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Philip Toltzis's work include Pneumonia and Respiratory Infections (18 papers), Antibiotic Resistance in Bacteria (16 papers) and Nosocomial Infections in ICU (16 papers). Philip Toltzis is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), Antibiotic Resistance in Bacteria (16 papers) and Nosocomial Infections in ICU (16 papers). Philip Toltzis collaborates with scholars based in United States, Uganda and Germany. Philip Toltzis's co-authors include Michael Dul, Theoklis E. Zaoutis, Julia Shaklee Sammons, Jeffrey L. Blumer, Michael R. Jacobs, Ann Salvator, Claudia K. Hoyen, Sarah Smathers, Susan Coffin and Jason Kim and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Philip Toltzis

81 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Toltzis United States 23 673 655 340 327 244 86 1.6k
Hsieh‐Shong Leu Taiwan 22 554 0.8× 407 0.6× 402 1.2× 327 1.0× 148 0.6× 44 1.4k
Yee Gyung Kwak South Korea 24 518 0.8× 550 0.8× 398 1.2× 196 0.6× 267 1.1× 118 1.7k
Tobi Karchmer United States 17 736 1.1× 723 1.1× 293 0.9× 233 0.7× 215 0.9× 21 1.8k
Shailendra N. Banerjee United States 13 530 0.8× 408 0.6× 364 1.1× 428 1.3× 241 1.0× 17 1.9k
Ayşe Erbay Türkiye 23 479 0.7× 570 0.9× 297 0.9× 171 0.5× 346 1.4× 87 1.6k
S. Alfandari France 22 1.0k 1.5× 951 1.5× 158 0.5× 344 1.1× 145 0.6× 112 2.1k
Ángel Asensio Spain 26 782 1.2× 823 1.3× 314 0.9× 228 0.7× 125 0.5× 101 1.9k
Shmuel Benenson Israel 23 376 0.6× 421 0.6× 350 1.0× 131 0.4× 202 0.8× 77 1.3k
Joan Hebden United States 16 382 0.6× 435 0.7× 479 1.4× 185 0.6× 135 0.6× 54 1.3k
Sharon Welbel United States 20 397 0.6× 655 1.0× 137 0.4× 368 1.1× 122 0.5× 28 1.6k

Countries citing papers authored by Philip Toltzis

Since Specialization
Citations

This map shows the geographic impact of Philip Toltzis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Toltzis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Toltzis more than expected).

Fields of papers citing papers by Philip Toltzis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Toltzis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Toltzis. The network helps show where Philip Toltzis may publish in the future.

Co-authorship network of co-authors of Philip Toltzis

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Toltzis. A scholar is included among the top collaborators of Philip Toltzis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Toltzis. Philip Toltzis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clayton, Jason A., Nori Minich, Annette Jencson, et al.. (2024). Molecular Epidemiology of Clostridioides difficile Colonization in Families With Infants. Open Forum Infectious Diseases. 11(6). ofae299–ofae299.
2.
Toltzis, Philip. (2018). 50 Years Ago in The Journal of Pediatrics. The Journal of Pediatrics. 197. 56–56. 2 indexed citations
3.
Toltzis, Philip. (2016). 50 Years Ago in The Journal of Pediatrics. The Journal of Pediatrics. 175. 73–73. 1 indexed citations
4.
Toltzis, Philip, Michelle M. Nerandzic, Elie Saade, et al.. (2012). High Proportion of False-Positive Clostridium difficile Enzyme Immunoassays for Toxin A and B in Pediatric Patients. Infection Control and Hospital Epidemiology. 33(2). 175–179. 18 indexed citations
5.
Sandrock, Christian, Philip Toltzis, Robert K. Kanter, et al.. (2011). Treatment and triage recommendations for pediatric emergency mass critical care. Pediatric Critical Care Medicine. 12(6 Suppl). S109–S119. 21 indexed citations
6.
Kim, Jason, Sarah Smathers, Priya A. Prasad, et al.. (2011). Risk Factors and Outcomes Associated With Severe Clostridium difficile Infection in Children. The Pediatric Infectious Disease Journal. 31(2). 134–138. 101 indexed citations
7.
Pérez, Federico, Andrea Endimiani, Amy J. Ray, et al.. (2010). Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. Journal of Antimicrobial Chemotherapy. 65(8). 1807–1818. 156 indexed citations
8.
Toltzis, Philip, Alexis Elward, Daniela Davis, et al.. (2010). Opportunities for antibiotic reduction in mechanically ventilated children*. Pediatric Critical Care Medicine. 12(3). 282–285. 2 indexed citations
9.
Toltzis, Philip & Michele C. Walsh. (2010). Recently tested strategies to reduce nosocomial infections in the neonatal intensive care unit. Expert Review of Anti-infective Therapy. 8(2). 235–242. 8 indexed citations
10.
Toltzis, Philip, Michael Dul, Mary Ann O’Riordan, et al.. (2009). Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit*. Pediatric Critical Care Medicine. 10(1). 49–54. 6 indexed citations
11.
Toltzis, Philip, Michael Dul, Mary Ann O’Riordan, Michael R. Jacobs, & Jeffrey L. Blumer. (2006). Serogroup 19 Pneumococci Containing Both mef and erm Macrolide Resistance Determinants in an American City. The Pediatric Infectious Disease Journal. 25(1). 19–24. 16 indexed citations
12.
Hujer, Andrea M., Kristine M. Hujer, Steven H. Marshall, et al.. (2002). A Clinical Strain of Escherichia coli Possessing CMY-2 Plasmid-Mediated Amp C β -Lactamase: An Emerging Concern in Pediatrics?. Microbial Drug Resistance. 8(4). 329–333. 10 indexed citations
13.
Neely, Michael & Philip Toltzis. (2001). Infection control in pediatric hospitals. Current Opinion in Infectious Diseases. 14(4). 449–453. 5 indexed citations
14.
Toltzis, Philip, et al.. (2001). Etiology of Fever and Opportunities for Reduction of Antibiotic Use in a Pediatric Intensive Care Unit. Infection Control and Hospital Epidemiology. 22(8). 499–504. 16 indexed citations
15.
Toltzis, Philip, et al.. (1999). Human Immunodeficiency Virus (HIV)-Related Risk-Taking Behaviors in Women Attending Inner-City Prenatal Clinics in the Mid-West. Journal of Perinatology. 19(7). 483–487. 9 indexed citations
16.
Toltzis, Philip, et al.. (1998). Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods in a pediatric intensive care unit. Critical Care Medicine. 26(11). 1893–1899. 46 indexed citations
17.
Toltzis, Philip & Jeffrey L. Blumer. (1995). Antibiotic-Resistant Gram-negative Bacteria in the Critical Care Setting. Pediatric Clinics of North America. 42(3). 687–702. 30 indexed citations
18.
Toltzis, Philip, Tracy Mourton, & Terry Magnuson. (1994). Comparative Embryonic Cytotoxicity of Antiretroviral Nucleosides. The Journal of Infectious Diseases. 169(5). 1100–1102. 19 indexed citations
19.
Toltzis, Philip, Tracy Mourton, & Terry Magnuson. (1993). Comparative embryonic cytotoxicity of antiretroviral nucleosides. Clinical Pharmacology & Therapeutics. 53(2). 148. 1 indexed citations
20.
Mmiro, Francis, Christopher Ndugwa, Laura Guay, et al.. (1993). Effect of human immunodeficiency virus-1 infection on the outcome of pregnancy in Ugandan women.. 4(2). 67–73. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hsieh‐Shong Leu Breakdown of academic impact, for papers by Yee Gyung Kwak Breakdown of academic impact, for papers by Tobi Karchmer Breakdown of academic impact, for papers by Shailendra N. Banerjee Breakdown of academic impact, for papers by Ayşe Erbay Breakdown of academic impact, for papers by S. Alfandari Breakdown of academic impact, for papers by Ángel Asensio Breakdown of academic impact, for papers by Shmuel Benenson Breakdown of academic impact, for papers by Joan Hebden Breakdown of academic impact, for papers by Sharon Welbel
Rankless by CCL
2026